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Abstract The members of the secretin receptor family of G-
protein-coupled receptors share no significant sequence similarity 
to the more familiar rhodopsin-like family. However, multiple 
sequence alignment analysis reveals seven hydrophobic regions 
with significant a-helical periodicity. Residues that are likely to 
be buried on the interior of the helical bundle and others that are 
likely to contact the lipid bilayer are identified. A predicted 
arrangement of the helical bundle is described in which, by 
comparison with the arrangement in the rhodopsin family, helices 
2 and 7 are more buried within the bundle while helix 3 is more 
exposed to the lipid bilayer. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The investigation of the structure and function of G-pro-
tein-coupled receptors (GPCR) has been the subject of numer-
ous studies over the past decade [1-5]. However, the vast 
majority of this work has concentrated upon the rhodopsin-
like GPCRs and, in particular, the ß2-adrenergic receptor and 
rhodopsin itself. Significant advances in the elucidation of the 
3-dimensional structure of rhodopsin have been made in re-
cent years which have, in addition to multiple sequence align-
ment analysis and indirect structural studies, provided a pre-
liminary picture of the arrangement of the helices in the 
transmembrane bundle [6-11]. 
The receptors of the rhodopsin family are characterised by 
a number of highly conserved regions, or fingerprints, that can 
be used to align sequences that would otherwise be too diver-
gent for meaningful comparison [12]. However, the cloning of 
the secretin receptor and a variety of related GPCRs sug-
gested a distinct GPCR family (the SecR family) that did 
not match the rhodopsin family fingerprint [13,14]. Since these 
receptors possess the seven putative transmembrane oc-helices 
that characterise GPCRs, it is reasonable to assume that the 
general fold of the transmembrane bundle in the two families 
is likely to be conserved. However, the absence of significant 
sequence identity allows for the possibility of significant 
movements between the relative positions of equivalent a-heli-
ces, as has been observed in the globin family [15]. In addi-
tion, the absence of a reliable sequence alignment of the two 
families means that the deduced internal faces of the helices 
and the construction of molecular models of the SecR family 
must be deduced from first principles, rather than by compar-
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ison with those based upon rhodopsin [2]. Furthermore, the 
paucity of experimental data relating to the structure of SecR 
family GPCRs means that automated modelling procedures 
using experimentally derived distance constraints are inappro-
priate [16]. This paper describes the analysis of a multiple 
sequence alignment of members of the SecR family which 
has enabled a prediction of the global arrangement of the 
helix bundle and the positioning of individual residues within 
this domain. Since the number of structure/function studies of 
this family of receptors is increasing rapidly, the models pre-
sented here will be useful for the planning of experiments, 
especially those which require knowledge of the contact points 
between transmembrane helices. 
2. Methods 
Members of the SecR family were identified using the PRINTS 
database [17] and complete sequences were extracted from the OWL 
sequence database v28.0 [18]. Sequence alignments were carried out 
using the program MALIGN [19] and trees were constructed using 
PHYLIP [20] with distances calculated as — 100(log[percentage iden-
tity]/100). Fourier transform analysis was carried out using the com-
puter programs within PERSCAN v7.0 as described previously [21]. 
The sequence alignment was scanned with a window of 18 residues 
using PERSCAN and the window with the highest a-helical perio-
dicity (AP value [21]) within each hydrophobic region was defined as a 
transmembrane region. Note that if any sequences are identical within 
the window used in the PERSCAN analysis, the computer program 
only includes one such sequence in order to avoid bias. The sequence 
pattern at each position in each alignment was used to estimate the 
extent to which that position is buried or lipid-accessible, based upon 
substitution tables calculated from alignments of proteins of known 
structure as described previously [21]. The periodicity in the predicted 
accessibilities was then calculated using a Fourier transform proce-
dure to yield both an estimation of the extent of the a-helical perio-
dicity (APmax) and a predicted direction of the internal face of the 
helix (0m„) relative to the first residue in that helix. 
The SecR family sequences were grouped into either five major 
groups or 15 smaller subsets of closely related receptors based upon 
the clustering in the dendrogram (Fig. 1). A buried position is defined 
where either (i) a residue (other than glycine or proline) is completely 
conserved over three of the five major groups or (ii) at least one 
charged residue (Asp, Glu, His, Lys or Arg) exists within the central 
ten residues of the helix. A position is defined as being lipid accessible 
if it is variable within one of the 15 smaller subsets of closely related 
receptors. A variable position is defined as one where, for at least one 
of the smaller subsets, all the residues do not fall into one of the 
following nine residue groupings: (A, L, V, I, M), (L, V, I, M, F), 
(F, Y, W, H), (A, G, P, S, T), (S, T, C), (N, Q, H), (S, T, N, Q), 
(H, R, K), (D, E, N, Q). 
3. Results and discussion 
The Fourier transform analysis of the transmembrane se-
quence alignments are summarised in Table 1. A value of 
APmax greater than 2 suggests that the a-helical periodicity 
is significant [21,22]. As can be seen from Table 1, all the 
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Fig. 1. Dendrogram depicting the clustering of the SecR family GPCRs based upon their relative levels of sequence identity. 
APmax values are greater or equal to 3.38 which suggests that 
all seven of the hydrophobic regions in the SecR family form 
transmembrane a-helices. 
The Fourier transform analysis predicts the direction of the 
internal face of each helix (Table 1) but it does not estimate 
the extent of the buried face. For example, although a Fourier 
transform analysis of the rhodopsin-like GPCRs was able to 
show significant a-helical periodicity and predict the internal 
face of each helix [23], a more detailed analysis of the family 
was required, alongside the projection map of rhodopsin, to 
predict the extent to which each helix was buried within the 
helix bundle [7]. In the latter analysis, Baldwin used a large 
sequence alignment of rhodopsin-like GPCRs to predict 
whether individual residue positions on a helix were buried 
or lipid-accessible, which in turn allowed the extent of the 
exposure of the entire helix to be estimated. It was then pos-
sible to assign each helix to a peak in the projection map of 
rhodopsin. 
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Fig. 2. Sequence alignment of the 7 putative transmembrane regions of the SecR family of GPCRs. Bold horizontal lines separate the 5 major 
clusters, while dotted horizontal lines separate the 15 smaller groups of closely related sequences. White letters upon black backgrounds repre-
sent residue positions predicted to be buried. Boxed letters represent residue positions predicted to be lipid-accessible. The consensus prediction 
is shown on the final row with buried positions depicted with black squares and lipid-accessible residues depicted with asterisks (*). Conserved 
Gly and Pro residues are shown in bold. 
In order to predict the arrangement of the helices in the 
SecR family of GPCRs, a similar procedure was used to com-
plement the Fourier transform analysis. The rules for defining 
whether a residue was either buried or in contact with the 
bilayer were based upon general principles of protein structure 
as determined from a variety of studies [e.g. [7,21,22,24]]. 
Charged residues are unlikely to contact the lipid region of 
the bilayer although those on the extremities of the transmem-
brane helices may interact with the polar phospholipid head-
group region. Hence, the presence of at least one charged 
residue within the central 10 positions was considered as de-
fining that position as buried. 
A second property used to identify the location of residues 
relies upon the observation that residues buried in the core of 
a protein, which are under greater conformational restraint, 
tend to be more conserved than those that are exposed to the 
lipid [21-24]. However, the special conformational properties 
of glycine and proline [25] could allow these residues to influ-
ence the properties of an oc-helix even when they are on the 
external lipid-accessible face; hence they were given special 
consideration. In measuring the extent of conservation, it is 
more significant if a residue is conserved across sequences that 
are otherwise divergent, whereas a variable position is more 
significant in sequences that are closely related [7]. Therefore, 
the clustering of the sequences in the dendrogram was used to 
group them either into subsets of closely related sequences 
within which variable positions are more significant, or else 
into larger more divergent groups between which conserved 
positions are more significant. 
The dendrogram calculated from the full sequence align-
ment of the SecR family is shown in Fig. 1. The clustering 
pattern allows for the division of the SecR sequences into five 
major categories (at approximately the 45% identity level) or 
else into 15 smaller subsets (at approximately the 75% identity 
level). Fig. 2 shows the alignment of the seven putative trans-
membrane regions with the five larger groups separated by 
bold horizontal lines and the 15 smaller subsets by dotted 
horizontal lines. The residues used to define buried positions 
are shown with a white letter upon black background while 
those used to define a lipid accessible position are shown with 
boxed letters. An accepted numbering convention for the fu-
ture analysis of mutations in this family of receptors would be 
extremely useful. A convention in this paper, similar to that 
used in other receptor families, is based upon the alignment in 
Fig. 2 in which the helix number is followed by the position of 
the residue in that helix — for example, position 3.11 repre-
sents the eleventh position in transmembrane helix 3 (TM3). 
The final row of Fig. 2 displays the overall consensus pre-
Table 1 
Analysis of a-helical periodicity in the transmembrane regions 
^ " r n a . x "max 
TM1 
TM2 
TM3 
TM4 
TM5 
TM6 
TM7 
5.52 
4.24 
3.78 
3.89 
4.20 
3.47 
3.38 
148' 
320' 
38' 
238' 
70' 
234' 
253' 
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Fig. 3. Predicted arrangement of the SecR family transmembrane domain using the sequence of the rat GLP-1 receptor (GLPR_RAT; see 
legend to Fig. 2 for consensus prediction conventions). 
diction with the buried positions shown with black squares 
and the lipid accessible positions shown with asterisks. If 
each sequence is represented as a helical wheel, it can be 
seen that, in general, the predicted buried and lipid-accessible 
faces of the helices are mutually exclusive (Fig. 3) with only 
two exceptions. In the first of these, there is an overlap be-
tween the buried and lipid-accessible faces on TM2. However, 
in this case the accuracy of the lipid-accessible prediction is 
questionable since it is based upon the presence of an arginine 
residue at position 2.15 of the human growth hormone-releas-
ing hormone-receptor (GRFR_HXJMAN). This is likely to be 
a sequence error since a second sequence for the same human 
receptor (A45367) suggests that this residue is an alanine as it 
is in the rat, mouse and pig homologues. Further evidence 
that this position is buried comes from mutagenesis work 
on the opossum PTH receptor in which the Ser233-Ala sub-
stitution results in a greater than 50% reduction of the max-
imal stimulation of adenylyl cyclase activity as well as a right-
ward shift in the dose response curve [26]. The second overlap 
of the predicted buried and lipid-accessible faces is in TM6, 
although the overlap is of only one residue. This may indicate 
the direction of the tilt of TM6 since it suggests that the 
extracellular C-terminus of the helix tilts away from the bun-
dle while the cytoplasmic N-terminus tilts towards it. 
(a) rhodopsin-like 
© 
® © 
© © 
© 
© 
(b) secreti 
© 
n receptor-like 
© © 
© ^ © 
© © 
Fig. 4. Comparison of the arrangement of the transmembrane helices in the rhodopsin-like and SecR-like GPCRs. 
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CONSERVED RESIDUE EXPOSED 
Fig. 5. Model of the transmembrane domain of the SecR-like GPCRs based upon the arrangement of rhodopsin [6] (see legend to Fig. 2 for 
consensus prediction conventions). 
Fig. 3 shows the seven helical wheels placed in a sequential 
anti-clockwise arrangement with all the predicted buried res-
idues either orientated towards the interior of the helix bundle 
or in contact with neighbouring helices. The arrangement of 
the helices appears to differ from that observed for rhodopsin 
[6] in that helix 3 is more exposed while helices 2 and 7 are 
more buried (Fig. 4). Relative movements between helices in 
distantly related proteins have been observed, notably in the 
globin family [15], although their overall fold is conserved. It 
should therefore not be too surprising if differences are ob-
served between the transmembrane helices of the rhodopsin-
like and secretin receptor-like GPCRs since they share no 
significant sequence identity. 
However, if the helices of the SecR family are arranged a 
priori in a similar fashion to those of rhodopsin, then it is 
possible to place the vast majority of the predicted buried 
residues in contact with neighbouring helices (Fig. 5). The 
only significant exception is position 2.11 which would now 
be on the lipid accessible face of TM2, despite containing a 
leucine residue in all but two of the sequences. It would be 
difficult to explain why such a conserved residue should exist 
on the lipid accessible face but the possibility that it plays an 
important role in some aspect of the receptor structure/func-
tion (e.g. the protein folding mechanism, dimer formation, 
etc.) cannot be completely ignored. 
The SecR family is characterised by a relatively large N-
terminal domain containing several highly conserved residues 
which include six cysteines that may form disulphide bonds. 
Although the transmembrane domain of some GPCRs plays a 
dominant role in forming the ligand binding pocket [1], there 
is growing evidence that the SecR family extracellular domain 
is the major factor in the peptide binding site [e.g. [27,28]]. 
Hence the models described here are unlikely to be useful in 
predicting the majority of the ligand interaction points. How-
ever, the transmembrane domain is critical for mediating the 
conformational changes required for the transduction of the 
extracellular signal to the intracellular G protein. Hence the 
SecR family models described here will be useful in predicting 
experiments for locating 'hot spots' for constitutively active 
receptors, as has recently been carried out for the angiotensin 
ATi receptor [29]. Moreover, the models will be useful in 
designing experiments which aim to identify contact points 
between transmembrane helices, as has been carried out for 
rhodopsin [11]. 
A potential helix-helix contact point has been identified in 
the PTH receptor between Arg233 (position 2.12) and Gin451 
(position 7.06). Substitution of Arg233 caused upto a 200-fold 
reduction in agonist binding affinity without effecting antago-
nist binding. However, the agonist binding affinity was re-
stored by a second mutation in which Gin451 was substituted 
with Lys [30]. The suggested functional coupling of these res-
idues is compatible with the model in Fig. 3 (Ccc-Ca distance 
of approximately 8 A O but it is more difficult to envisage in 
''' The co-ordinates of 3-dimensional model based upon Fig. 3, as 
well as a tentative model in which the helices have been tilted and 
loops added, can be obtained from http://swift.embl-heidelberg.de/ 
7tm/models/. 
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the model depicted in Fig. 5 where TM3 blocks the path 
between TM2 and TM7. In addition, the predicted buried 
residues at positions 2.2, 2.8, 2.12 and 2.15 have been shown 
to be functionally important in the PTH receptor [26]. 
Therefore, in summary, a model for the transmembrane 
domain of the SecR family of GPCRs is presented. The over-
all structure of the domain is based upon the fold of the 
rhodopsin family — that is, a 7 helical bundle in which the 
helices are arranged in an anti-clockwise fashion when viewed 
from the extracellular side of the bilayer [10]. However, the 
precise positioning of individual residues within this helical 
bundle was derived from first principles through the analysis 
of a multiple sequence alignment. If all the conserved residues 
are positioned in the interior of the helix bundle, then the 
shape of the bundle differs from that of rhodopsin in that 
TM3 is more exposed while TM2 and TM7 are more buried. 
Alternatively, if the helices are arranged a priori in a similar 
fashion to those in the rhodopsin model, then only one highly 
conserved position is significantly exposed to the bilayer. It is 
not clear which arrangement is most likely; the model de-
scribed in Fig. 3 is more objective and rule-based and appears 
to agree more fully with the limited mutagenesis data. On the 
other hand, the model shown in Fig. 5 is based upon the 
arrangement of a structural homologue. Of course, both of 
the 2-dimensional models presented here do not take into 
account any relative tilting between the transmembrane heli-
ces which will affect, to a limited degree, the contact points 
between neighbouring helices ' ' ' . However, such models are 
open to empirical testing and should be extremely useful for 
the planning of experiments that require knowledge of contact 
points between transmembrane helices [e.g. [9-11,29]]. 
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